Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stavroula Baritaki

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Cancers|August 29, 2018
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and ImpactApostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki, et al.
Cells|August 9, 2024
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?Athina A Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 5, 2022
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggabilityGiasemi C Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Journal of Clinical Medicine|October 17, 2019
Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular CrosstalkStavroula Baritaki, Eelco de Bree, Ekaterini Chatzaki, et al.
Cancers|October 3, 2019
Current Perspectives in Cancer ImmunotherapyTheodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Antioxidants & Redox Signaling|July 19, 2023
Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products <i>via</i> the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic ImplicationsIndy Bui, Stavroula Baritaki, Massimo Libra, et al.
Cancer Research|October 22, 2009
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitizationStavroula Baritaki, Kam Yeung, Michael Palladino, et al.
International Journal of Molecular Medicine|July 14, 2005
In vitro inhibition of R5 HIV-1 infectivity by X4 V3-derived synthetic peptidesStavroula Baritaki, Matthias T Dittmar, Demetrios A Spandidos, et al.
Roumanian Archives of Microbiology and Immunology|March 17, 2009
Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in GreeceIoannis K Neonakis, Stavroula Baritaki, Alexandros Georgiladakis, et al.
Drug Discovery Today|September 15, 2018
Do urocortins have a role in treating cardiovascular disease?Ekaterini Chatzaki, Nikoleta Kefala, Ioannis Drosos, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Cancers|August 29, 2018
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and ImpactApostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki, et al.
Cells|August 9, 2024
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?Athina A Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 5, 2022
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggabilityGiasemi C Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Journal of Clinical Medicine|October 17, 2019
Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular CrosstalkStavroula Baritaki, Eelco de Bree, Ekaterini Chatzaki, et al.
Cancers|October 3, 2019
Current Perspectives in Cancer ImmunotherapyTheodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Antioxidants & Redox Signaling|July 19, 2023
Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products <i>via</i> the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic ImplicationsIndy Bui, Stavroula Baritaki, Massimo Libra, et al.
Cancer Research|October 22, 2009
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitizationStavroula Baritaki, Kam Yeung, Michael Palladino, et al.
International Journal of Molecular Medicine|July 14, 2005
In vitro inhibition of R5 HIV-1 infectivity by X4 V3-derived synthetic peptidesStavroula Baritaki, Matthias T Dittmar, Demetrios A Spandidos, et al.
Roumanian Archives of Microbiology and Immunology|March 17, 2009
Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in GreeceIoannis K Neonakis, Stavroula Baritaki, Alexandros Georgiladakis, et al.
Drug Discovery Today|September 15, 2018
Do urocortins have a role in treating cardiovascular disease?Ekaterini Chatzaki, Nikoleta Kefala, Ioannis Drosos, et al.
Pageof 8